Global Tumour Vaccine Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Tumour Vaccine Market Size 2017-2028

2.1.2 Tumour Vaccine Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Tumour Vaccine Segment by Type

2.2.1 Personalized Vaccine

2.2.2 Off-the shelf Vaccine

2.3 Tumour Vaccine Market Size by Type

2.3.1 Tumour Vaccine Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Tumour Vaccine Market Size Market Share by Type (2017-2022)

2.4 Tumour Vaccine Segment by Application

2.4.1 Lung Cancer

2.4.2 Melanoma Cancer

2.4.3 Gastrointestinal Cancer

2.4.4 Brain Cancer

2.4.5 Others

2.5 Tumour Vaccine Market Size by Application

2.5.1 Tumour Vaccine Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Tumour Vaccine Market Size Market Share by Application (2017-2022)

3 Tumour Vaccine Market Size by Player

3.1 Tumour Vaccine Market Size Market Share by Players

3.1.1 Global Tumour Vaccine Revenue by Players (2020-2022)

3.1.2 Global Tumour Vaccine Revenue Market Share by Players (2020-2022)

3.2 Global Tumour Vaccine Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Tumour Vaccine by Regions

4.1 Tumour Vaccine Market Size by Regions (2017-2022)

4.2 Americas Tumour Vaccine Market Size Growth (2017-2022)

4.3 APAC Tumour Vaccine Market Size Growth (2017-2022)

4.4 Europe Tumour Vaccine Market Size Growth (2017-2022)

4.5 Middle East & Africa Tumour Vaccine Market Size Growth (2017-2022)

5 Americas

5.1 Americas Tumour Vaccine Market Size by Country (2017-2022)

5.2 Americas Tumour Vaccine Market Size by Type (2017-2022)

5.3 Americas Tumour Vaccine Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Tumour Vaccine Market Size by Region (2017-2022)

6.2 APAC Tumour Vaccine Market Size by Type (2017-2022)

6.3 APAC Tumour Vaccine Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Tumour Vaccine by Country (2017-2022)

7.2 Europe Tumour Vaccine Market Size by Type (2017-2022)

7.3 Europe Tumour Vaccine Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Tumour Vaccine by Region (2017-2022)

8.2 Middle East & Africa Tumour Vaccine Market Size by Type (2017-2022)

8.3 Middle East & Africa Tumour Vaccine Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Tumour Vaccine Market Forecast

10.1 Global Tumour Vaccine Forecast by Regions (2023-2028)

10.1.1 Global Tumour Vaccine Forecast by Regions (2023-2028)

10.1.2 Americas Tumour Vaccine Forecast

10.1.3 APAC Tumour Vaccine Forecast

10.1.4 Europe Tumour Vaccine Forecast

10.1.5 Middle East & Africa Tumour Vaccine Forecast

10.2 Americas Tumour Vaccine Forecast by Country (2023-2028)

10.2.1 United States Tumour Vaccine Market Forecast

10.2.2 Canada Tumour Vaccine Market Forecast

10.2.3 Mexico Tumour Vaccine Market Forecast

10.2.4 Brazil Tumour Vaccine Market Forecast

10.3 APAC Tumour Vaccine Forecast by Region (2023-2028)

10.3.1 China Tumour Vaccine Market Forecast

10.3.2 Japan Tumour Vaccine Market Forecast

10.3.3 Korea Tumour Vaccine Market Forecast

10.3.4 Southeast Asia Tumour Vaccine Market Forecast

10.3.5 India Tumour Vaccine Market Forecast

10.3.6 Australia Tumour Vaccine Market Forecast

10.4 Europe Tumour Vaccine Forecast by Country (2023-2028)

10.4.1 Germany Tumour Vaccine Market Forecast

10.4.2 France Tumour Vaccine Market Forecast

10.4.3 UK Tumour Vaccine Market Forecast

10.4.4 Italy Tumour Vaccine Market Forecast

10.4.5 Russia Tumour Vaccine Market Forecast

10.5 Middle East & Africa Tumour Vaccine Forecast by Region (2023-2028)

10.5.1 Egypt Tumour Vaccine Market Forecast

10.5.2 South Africa Tumour Vaccine Market Forecast

10.5.3 Israel Tumour Vaccine Market Forecast

10.5.4 Turkey Tumour Vaccine Market Forecast

10.5.5 GCC Countries Tumour Vaccine Market Forecast

10.6 Global Tumour Vaccine Forecast by Type (2023-2028)

10.7 Global Tumour Vaccine Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Pfizer

11.1.1 Pfizer Company Information

11.1.2 Pfizer Tumour Vaccine Product Offered

11.1.3 Pfizer Tumour Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Pfizer Main Business Overview

11.1.5 Pfizer Latest Developments

11.2 Merck & Co Inc

11.2.1 Merck & Co Inc Company Information

11.2.2 Merck & Co Inc Tumour Vaccine Product Offered

11.2.3 Merck & Co Inc Tumour Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Merck & Co Inc Main Business Overview

11.2.5 Merck & Co Inc Latest Developments

11.3 Eli Lilly and Company

11.3.1 Eli Lilly and Company Company Information

11.3.2 Eli Lilly and Company Tumour Vaccine Product Offered

11.3.3 Eli Lilly and Company Tumour Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Eli Lilly and Company Main Business Overview

11.3.5 Eli Lilly and Company Latest Developments

11.4 BioNTech

11.4.1 BioNTech Company Information

11.4.2 BioNTech Tumour Vaccine Product Offered

11.4.3 BioNTech Tumour Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 BioNTech Main Business Overview

11.4.5 BioNTech Latest Developments

11.5 Roche Holding AG

11.5.1 Roche Holding AG Company Information

11.5.2 Roche Holding AG Tumour Vaccine Product Offered

11.5.3 Roche Holding AG Tumour Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Roche Holding AG Main Business Overview

11.5.5 Roche Holding AG Latest Developments

11.6 OSE Immunotherapeutics

11.6.1 OSE Immunotherapeutics Company Information

11.6.2 OSE Immunotherapeutics Tumour Vaccine Product Offered

11.6.3 OSE Immunotherapeutics Tumour Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 OSE Immunotherapeutics Main Business Overview

11.6.5 OSE Immunotherapeutics Latest Developments

11.7 Gritstone Bio

11.7.1 Gritstone Bio Company Information

11.7.2 Gritstone Bio Tumour Vaccine Product Offered

11.7.3 Gritstone Bio Tumour Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Gritstone Bio Main Business Overview

11.7.5 Gritstone Bio Latest Developments

11.8 Moderna

11.8.1 Moderna Company Information

11.8.2 Moderna Tumour Vaccine Product Offered

11.8.3 Moderna Tumour Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Moderna Main Business Overview

11.8.5 Moderna Latest Developments

11.9 Avidea Technologies

11.9.1 Avidea Technologies Company Information

11.9.2 Avidea Technologies Tumour Vaccine Product Offered

11.9.3 Avidea Technologies Tumour Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Avidea Technologies Main Business Overview

11.9.5 Avidea Technologies Latest Developments

11.10 Vaccibody AS

11.10.1 Vaccibody AS Company Information

11.10.2 Vaccibody AS Tumour Vaccine Product Offered

11.10.3 Vaccibody AS Tumour Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Vaccibody AS Main Business Overview

11.10.5 Vaccibody AS Latest Developments

11.11 Agenus Inc

11.11.1 Agenus Inc Company Information

11.11.2 Agenus Inc Tumour Vaccine Product Offered

11.11.3 Agenus Inc Tumour Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Agenus Inc Main Business Overview

11.11.5 Agenus Inc Latest Developments

11.12 Novogene

11.12.1 Novogene Company Information

11.12.2 Novogene Tumour Vaccine Product Offered

11.12.3 Novogene Tumour Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Novogene Main Business Overview

11.12.5 Novogene Latest Developments

11.13 ZIOPHARM Oncology

11.13.1 ZIOPHARM Oncology Company Information

11.13.2 ZIOPHARM Oncology Tumour Vaccine Product Offered

11.13.3 ZIOPHARM Oncology Tumour Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 ZIOPHARM Oncology Main Business Overview

11.13.5 ZIOPHARM Oncology Latest Developments

11.14 ISA Pharmaceuticals

11.14.1 ISA Pharmaceuticals Company Information

11.14.2 ISA Pharmaceuticals Tumour Vaccine Product Offered

11.14.3 ISA Pharmaceuticals Tumour Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 ISA Pharmaceuticals Main Business Overview

11.14.5 ISA Pharmaceuticals Latest Developments

11.15 BrightPath Biotherapeutics

11.15.1 BrightPath Biotherapeutics Company Information

11.15.2 BrightPath Biotherapeutics Tumour Vaccine Product Offered

11.15.3 BrightPath Biotherapeutics Tumour Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 BrightPath Biotherapeutics Main Business Overview

11.15.5 BrightPath Biotherapeutics Latest Developments

11.16 Vaximm AG

11.16.1 Vaximm AG Company Information

11.16.2 Vaximm AG Tumour Vaccine Product Offered

11.16.3 Vaximm AG Tumour Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Vaximm AG Main Business Overview

11.16.5 Vaximm AG Latest Developments

11.17 Medigene AG

11.17.1 Medigene AG Company Information

11.17.2 Medigene AG Tumour Vaccine Product Offered

11.17.3 Medigene AG Tumour Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Medigene AG Main Business Overview

11.17.5 Medigene AG Latest Developments

11.18 Genocea Biosciences Inc

11.18.1 Genocea Biosciences Inc Company Information

11.18.2 Genocea Biosciences Inc Tumour Vaccine Product Offered

11.18.3 Genocea Biosciences Inc Tumour Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 Genocea Biosciences Inc Main Business Overview

11.18.5 Genocea Biosciences Inc Latest Developments

11.19 Advaxis

11.19.1 Advaxis Company Information

11.19.2 Advaxis Tumour Vaccine Product Offered

11.19.3 Advaxis Tumour Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.19.4 Advaxis Main Business Overview

11.19.5 Advaxis Latest Developments

11.20 Nouscom

11.20.1 Nouscom Company Information

11.20.2 Nouscom Tumour Vaccine Product Offered

11.20.3 Nouscom Tumour Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.20.4 Nouscom Main Business Overview

11.20.5 Nouscom Latest Developments

12 Research Findings and Conclusion

Table 1. Tumour Vaccine Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Personalized Vaccine

Table 3. Major Players of Off-the shelf Vaccine

Table 4. Tumour Vaccine Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Tumour Vaccine Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Tumour Vaccine Market Size Market Share by Type (2017-2022)

Table 7. Tumour Vaccine Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Tumour Vaccine Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Tumour Vaccine Market Size Market Share by Application (2017-2022)

Table 10. Global Tumour Vaccine Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Tumour Vaccine Revenue Market Share by Player (2020-2022)

Table 12. Tumour Vaccine Key Players Head office and Products Offered

Table 13. Tumour Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Tumour Vaccine Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Tumour Vaccine Market Size Market Share by Regions (2017-2022)

Table 18. Americas Tumour Vaccine Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Tumour Vaccine Market Size Market Share by Country (2017-2022)

Table 20. Americas Tumour Vaccine Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Tumour Vaccine Market Size Market Share by Type (2017-2022)

Table 22. Americas Tumour Vaccine Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Tumour Vaccine Market Size Market Share by Application (2017-2022)

Table 24. APAC Tumour Vaccine Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Tumour Vaccine Market Size Market Share by Region (2017-2022)

Table 26. APAC Tumour Vaccine Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Tumour Vaccine Market Size Market Share by Type (2017-2022)

Table 28. APAC Tumour Vaccine Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Tumour Vaccine Market Size Market Share by Application (2017-2022)

Table 30. Europe Tumour Vaccine Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Tumour Vaccine Market Size Market Share by Country (2017-2022)

Table 32. Europe Tumour Vaccine Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Tumour Vaccine Market Size Market Share by Type (2017-2022)

Table 34. Europe Tumour Vaccine Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Tumour Vaccine Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Tumour Vaccine Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Tumour Vaccine Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Tumour Vaccine Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Tumour Vaccine Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Tumour Vaccine Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Tumour Vaccine Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Tumour Vaccine

Table 43. Key Market Challenges & Risks of Tumour Vaccine

Table 44. Key Industry Trends of Tumour Vaccine

Table 45. Global Tumour Vaccine Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Tumour Vaccine Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Tumour Vaccine Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Tumour Vaccine Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Tumour Vaccine Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Tumour Vaccine Market Size Market Share Forecast by Application (2023-2028)

Table 51. Pfizer Details, Company Type, Tumour Vaccine Area Served and Its Competitors

Table 52. Pfizer Tumour Vaccine Product Offered

Table 53. Pfizer Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Pfizer Main Business

Table 55. Pfizer Latest Developments

Table 56. Merck & Co Inc Details, Company Type, Tumour Vaccine Area Served and Its Competitors

Table 57. Merck & Co Inc Tumour Vaccine Product Offered

Table 58. Merck & Co Inc Main Business

Table 59. Merck & Co Inc Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Merck & Co Inc Latest Developments

Table 61. Eli Lilly and Company Details, Company Type, Tumour Vaccine Area Served and Its Competitors

Table 62. Eli Lilly and Company Tumour Vaccine Product Offered

Table 63. Eli Lilly and Company Main Business

Table 64. Eli Lilly and Company Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Eli Lilly and Company Latest Developments

Table 66. BioNTech Details, Company Type, Tumour Vaccine Area Served and Its Competitors

Table 67. BioNTech Tumour Vaccine Product Offered

Table 68. BioNTech Main Business

Table 69. BioNTech Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. BioNTech Latest Developments

Table 71. Roche Holding AG Details, Company Type, Tumour Vaccine Area Served and Its Competitors

Table 72. Roche Holding AG Tumour Vaccine Product Offered

Table 73. Roche Holding AG Main Business

Table 74. Roche Holding AG Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Roche Holding AG Latest Developments

Table 76. OSE Immunotherapeutics Details, Company Type, Tumour Vaccine Area Served and Its Competitors

Table 77. OSE Immunotherapeutics Tumour Vaccine Product Offered

Table 78. OSE Immunotherapeutics Main Business

Table 79. OSE Immunotherapeutics Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. OSE Immunotherapeutics Latest Developments

Table 81. Gritstone Bio Details, Company Type, Tumour Vaccine Area Served and Its Competitors

Table 82. Gritstone Bio Tumour Vaccine Product Offered

Table 83. Gritstone Bio Main Business

Table 84. Gritstone Bio Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Gritstone Bio Latest Developments

Table 86. Moderna Details, Company Type, Tumour Vaccine Area Served and Its Competitors

Table 87. Moderna Tumour Vaccine Product Offered

Table 88. Moderna Main Business

Table 89. Moderna Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Moderna Latest Developments

Table 91. Avidea Technologies Details, Company Type, Tumour Vaccine Area Served and Its Competitors

Table 92. Avidea Technologies Tumour Vaccine Product Offered

Table 93. Avidea Technologies Main Business

Table 94. Avidea Technologies Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Avidea Technologies Latest Developments

Table 96. Vaccibody AS Details, Company Type, Tumour Vaccine Area Served and Its Competitors

Table 97. Vaccibody AS Tumour Vaccine Product Offered

Table 98. Vaccibody AS Main Business

Table 99. Vaccibody AS Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Vaccibody AS Latest Developments

Table 101. Agenus Inc Details, Company Type, Tumour Vaccine Area Served and Its Competitors

Table 102. Agenus Inc Tumour Vaccine Product Offered

Table 103. Agenus Inc Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Agenus Inc Main Business

Table 105. Agenus Inc Latest Developments

Table 106. Novogene Details, Company Type, Tumour Vaccine Area Served and Its Competitors

Table 107. Novogene Tumour Vaccine Product Offered

Table 108. Novogene Main Business

Table 109. Novogene Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. Novogene Latest Developments

Table 111. ZIOPHARM Oncology Details, Company Type, Tumour Vaccine Area Served and Its Competitors

Table 112. ZIOPHARM Oncology Tumour Vaccine Product Offered

Table 113. ZIOPHARM Oncology Main Business

Table 114. ZIOPHARM Oncology Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 115. ZIOPHARM Oncology Latest Developments

Table 116. ISA Pharmaceuticals Details, Company Type, Tumour Vaccine Area Served and Its Competitors

Table 117. ISA Pharmaceuticals Tumour Vaccine Product Offered

Table 118. ISA Pharmaceuticals Main Business

Table 119. ISA Pharmaceuticals Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 120. ISA Pharmaceuticals Latest Developments

Table 121. BrightPath Biotherapeutics Details, Company Type, Tumour Vaccine Area Served and Its Competitors

Table 122. BrightPath Biotherapeutics Tumour Vaccine Product Offered

Table 123. BrightPath Biotherapeutics Main Business

Table 124. BrightPath Biotherapeutics Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 125. BrightPath Biotherapeutics Latest Developments

Table 126. Vaximm AG Details, Company Type, Tumour Vaccine Area Served and Its Competitors

Table 127. Vaximm AG Tumour Vaccine Product Offered

Table 128. Vaximm AG Main Business

Table 129. Vaximm AG Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 130. Vaximm AG Latest Developments

Table 131. Medigene AG Details, Company Type, Tumour Vaccine Area Served and Its Competitors

Table 132. Medigene AG Tumour Vaccine Product Offered

Table 133. Medigene AG Main Business

Table 134. Medigene AG Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 135. Medigene AG Latest Developments

Table 136. Genocea Biosciences Inc Details, Company Type, Tumour Vaccine Area Served and Its Competitors

Table 137. Genocea Biosciences Inc Tumour Vaccine Product Offered

Table 138. Genocea Biosciences Inc Main Business

Table 139. Genocea Biosciences Inc Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 140. Genocea Biosciences Inc Latest Developments

Table 141. Advaxis Details, Company Type, Tumour Vaccine Area Served and Its Competitors

Table 142. Advaxis Tumour Vaccine Product Offered

Table 143. Advaxis Main Business

Table 144. Advaxis Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 145. Advaxis Latest Developments

Table 146. Nouscom Details, Company Type, Tumour Vaccine Area Served and Its Competitors

Table 147. Nouscom Tumour Vaccine Product Offered

Table 148. Nouscom Main Business

Table 149. Nouscom Tumour Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 150. Nouscom Latest Developments

List of Figures

Figure 1. Tumour Vaccine Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Tumour Vaccine Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Tumour Vaccine Market Size Market Share by Type in 2021

Figure 7. Tumour Vaccine in Lung Cancer

Figure 8. Global Tumour Vaccine Market: Lung Cancer (2017-2022) & ($ Millions)

Figure 9. Tumour Vaccine in Melanoma Cancer

Figure 10. Global Tumour Vaccine Market: Melanoma Cancer (2017-2022) & ($ Millions)

Figure 11. Tumour Vaccine in Gastrointestinal Cancer

Figure 12. Global Tumour Vaccine Market: Gastrointestinal Cancer (2017-2022) & ($ Millions)

Figure 13. Tumour Vaccine in Brain Cancer

Figure 14. Global Tumour Vaccine Market: Brain Cancer (2017-2022) & ($ Millions)

Figure 15. Tumour Vaccine in Others

Figure 16. Global Tumour Vaccine Market: Others (2017-2022) & ($ Millions)

Figure 17. Global Tumour Vaccine Market Size Market Share by Application in 2021

Figure 18. Global Tumour Vaccine Revenue Market Share by Player in 2021

Figure 19. Global Tumour Vaccine Market Size Market Share by Regions (2017-2022)

Figure 20. Americas Tumour Vaccine Market Size 2017-2022 ($ Millions)

Figure 21. APAC Tumour Vaccine Market Size 2017-2022 ($ Millions)

Figure 22. Europe Tumour Vaccine Market Size 2017-2022 ($ Millions)

Figure 23. Middle East & Africa Tumour Vaccine Market Size 2017-2022 ($ Millions)

Figure 24. Americas Tumour Vaccine Value Market Share by Country in 2021

Figure 25. Americas Tumour Vaccine Consumption Market Share by Type in 2021

Figure 26. Americas Tumour Vaccine Market Size Market Share by Application in 2021

Figure 27. United States Tumour Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 28. Canada Tumour Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 29. Mexico Tumour Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 30. Brazil Tumour Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 31. APAC Tumour Vaccine Market Size Market Share by Region in 2021

Figure 32. APAC Tumour Vaccine Market Size Market Share by Application in 2021

Figure 33. China Tumour Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 34. Japan Tumour Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 35. Korea Tumour Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 36. Southeast Asia Tumour Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 37. India Tumour Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 38. Australia Tumour Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 39. Europe Tumour Vaccine Market Size Market Share by Country in 2021

Figure 40. Europe Tumour Vaccine Market Size Market Share by Type in 2021

Figure 41. Europe Tumour Vaccine Market Size Market Share by Application in 2021

Figure 42. Germany Tumour Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 43. France Tumour Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 44. UK Tumour Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 45. Italy Tumour Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 46. Russia Tumour Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 47. Middle East & Africa Tumour Vaccine Market Size Market Share by Region in 2021

Figure 48. Middle East & Africa Tumour Vaccine Market Size Market Share by Type in 2021

Figure 49. Middle East & Africa Tumour Vaccine Market Size Market Share by Application in 2021

Figure 50. Egypt Tumour Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 51. South Africa Tumour Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 52. Israel Tumour Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 53. Turkey Tumour Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 54. GCC Country Tumour Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 55. Americas Tumour Vaccine Market Size 2023-2028 ($ Millions)

Figure 56. APAC Tumour Vaccine Market Size 2023-2028 ($ Millions)

Figure 57. Europe Tumour Vaccine Market Size 2023-2028 ($ Millions)

Figure 58. Middle East & Africa Tumour Vaccine Market Size 2023-2028 ($ Millions)

Figure 59. United States Tumour Vaccine Market Size 2023-2028 ($ Millions)

Figure 60. Canada Tumour Vaccine Market Size 2023-2028 ($ Millions)

Figure 61. Mexico Tumour Vaccine Market Size 2023-2028 ($ Millions)

Figure 62. Brazil Tumour Vaccine Market Size 2023-2028 ($ Millions)

Figure 63. China Tumour Vaccine Market Size 2023-2028 ($ Millions)

Figure 64. Japan Tumour Vaccine Market Size 2023-2028 ($ Millions)

Figure 65. Korea Tumour Vaccine Market Size 2023-2028 ($ Millions)

Figure 66. Southeast Asia Tumour Vaccine Market Size 2023-2028 ($ Millions)

Figure 67. India Tumour Vaccine Market Size 2023-2028 ($ Millions)

Figure 68. Australia Tumour Vaccine Market Size 2023-2028 ($ Millions)

Figure 69. Germany Tumour Vaccine Market Size 2023-2028 ($ Millions)

Figure 70. France Tumour Vaccine Market Size 2023-2028 ($ Millions)

Figure 71. UK Tumour Vaccine Market Size 2023-2028 ($ Millions)

Figure 72. Italy Tumour Vaccine Market Size 2023-2028 ($ Millions)

Figure 73. Russia Tumour Vaccine Market Size 2023-2028 ($ Millions)

Figure 74. Spain Tumour Vaccine Market Size 2023-2028 ($ Millions)

Figure 75. Egypt Tumour Vaccine Market Size 2023-2028 ($ Millions)

Figure 76. South Africa Tumour Vaccine Market Size 2023-2028 ($ Millions)

Figure 77. Israel Tumour Vaccine Market Size 2023-2028 ($ Millions)

Figure 78. Turkey Tumour Vaccine Market Size 2023-2028 ($ Millions)

Figure 79. GCC Countries Tumour Vaccine Market Size 2023-2028 ($ Millions)